| Index | — | P/E | — | EPS (ttm) | -0.70 | Insider Own | — | Shs Outstand | 880.69M | Perf Week | 7.74% |
| Market Cap | 3.06B | Forward P/E | 13.98 | EPS next Y | 0.25 | Insider Trans | 0.00% | Shs Float | 376.28M | Perf Month | 30.83% |
| Enterprise Value | 6.31B | PEG | — | EPS next Q | 0.12 | Short Float | 11.09% | Perf Quarter | 19.59% | ||
| Income | -605.00M | P/S | 0.53 | EPS this Y | 50.14% | Short Ratio | 6.11 | Perf Half Y | 43.80% | ||
| Sales | 5.81B | P/B | 0.95 | EPS next Y | -23.04% | ROA | -5.93% | Short Interest | 41.71M | Perf YTD | 12.99% |
| Book/sh | 3.68 | P/C | 16.22 | EPS next 5Y | 5.06% | ROE | -18.06% | 52W High | 4.16 -17.43% | Perf Year | -11.45% |
| Cash/sh | 0.21 | P/FCF | 8.81 | EPS past 3/5Y | — | ROIC | 3.63% | 52W Low | 1.82 88.74% | Perf 3Y | -62.90% |
| Dividend Est. | — | EV/EBITDA | 76.08 | Sales past 3/5Y | 1.50% 4.63% | Gross Margin | 59.09% | Volatility | 4.39% 4.07% | Perf 5Y | -56.50% |
| Dividend TTM | — | EV/Sales | 1.09 | EPS Y/Y TTM | — | Oper. Margin | 5.00% | ATR (14) | 0.13 | Perf 10Y | -84.87% |
| Dividend Ex-Date | Feb 14, 2020 | Quick Ratio | 0.42 | Sales Y/Y TTM | -1.46% | Profit Margin | -10.42% | RSI (14) | 76.03 | Recom | 2.82 |
| Dividend Gr. 3/5Y | -37.00% -12.94% | Current Ratio | 0.75 | EPS Q/Q | 60.00% | SMA20 | 11.48% | Beta | 0.83 | Target Price | 2.86 |
| Payout | — | Debt/Eq | 1.06 | Sales Q/Q | 1.36% | SMA50 | 21.28% | Rel Volume | 1.15 | Prev Close | 3.48 |
| Employees | 11,335 | LT Debt/Eq | 1.04 | Earnings | Nov 04 | SMA200 | 37.49% | Avg Volume | 5.88M | Price | 3.44 |
| IPO Date | Jun 13, 2013 | Option/Short | Yes / Yes | EPS/Sales Surpr. | -224.46% 6.34% | Net Debt/EBITDA | 39.16 | Volume | 6,784,213 | Change | -1.29% |
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Oct-19-26 | Reiterated | Jefferies | Buy | $3.50 → $2.95 |
| Aug-25-26 | Reiterated | Morgan Stanley | Equal Weight | $2.50 → $2.75 |
| Aug-21-26 | Reiterated | Deutsche Bank | Hold | $2.00 → $3.00 |
| Aug-20-26 | Reiterated | Goldman Sachs | Neutral | $2.40 → $2.60 |
| Aug-20-26 | Reiterated | RBC Capital | Outperform | $8.00 → $3.00 |
| May-07-26 | Reiterated | Morgan Stanley | Equal Weight | $2.25 → $2.50 |
| Apr-14-26 | Reiterated | Barclays | Underweight | $2.50 → $2.00 |
| Feb-09-26 | Reiterated | Morgan Stanley | Equal Weight | $4.25 → $3.50 |
| Feb-09-26 | Reiterated | Canaccord Genuity | Hold | $3.50 → $2.50 |
| Feb-09-26 | Reiterated | Goldman Sachs | Neutral | $3.80 → $2.50 |
Coty Inc., together with its subsidiaries, manufactures, markets, distributes, and sells branded beauty products worldwide. It operates through two segments: the Prestige and Consumer Beauty. The company provides fragrance, color cosmetics, and skin and body care products. It offers prestige products through prestige retailers, including perfumeries, department stores, e-retailers, direct-to-consumer websites, and duty-free shops under the Burberry, Calvin Klein, Chloe, Davidoff, Escada, Etro, Gucci, Hugo Boss, Infiniment Coty Paris, Jil Sander, Joop!, Kylie Cosmetics by Kylie Jenner, Lancaster, Marc Jacobs, Orveda, philosophy, and Tiffany & Co. brands. The company provides beauty products through hypermarkets, supermarkets, drug stores, pharmacies, mid-tier department stores, traditional food and drug retailers, and e-commerce retailers under the Adidas, Beckham, Bozzano, Bourjois, Bruno Banani, CoverGirl, Jovan, LeGer by Lena Gercke, Max Factor, Mexx, Monange, Nautica, Paixao, Rimmel, Risque, Vera Wang, and Sally Hansen brands. It also sells its products through third-party distributors. The company was founded in 1904 and is headquartered in New York, New York. Coty Inc. is a subsidiary of JAB Beauty B.V.
Per-holder 13F data hasn't been ingested for this ticker yet.
| Line Item (USD, M) | TTM — | FY 2026 6/30/2026 | FY 2025 6/30/2025 | FY 2024 6/30/2024 | FY 2023 6/30/2023 | FY 2022 6/30/2022 | FY 2021 6/30/2021 | FY 2020 6/30/2020 | FY 2019 6/30/2019 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 5,807 | 5,807 | 5,893 | 6,118 | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 2,375 | 2,155 | 2,072 | 2,179 | — | — | — | — | — | |
| Gross Profit | 3,431 | 3,652 | 3,821 | 3,939 | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 3,100 | 3,108 | 3,104 | 3,163 | — | — | — | — | — | |
| Research and Development | 0 | 0 | 123 | 127 | — | — | — | — | — | |
| Other Operating Expense | 41 | 626 | 353 | 103 | — | — | — | — | — | |
| Operating Income | 290 | -81 | 241 | 547 | — | — | — | — | — | |
| Interest Expense | 210 | 155 | 227 | 252 | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | -691 | -373 | -359 | -91 | — | — | — | — | — | |
| Net Income Before Taxes | -611 | -610 | -345 | 205 | — | — | — | — | — | |
| Income Taxes | -19 | -20 | 5 | 95 | — | — | — | — | — | |
| Consolidated Net Income | -605 | -605 | -368 | 89 | — | — | — | — | — | |
| Net Income From Continuing Operations | -590 | -590 | -350 | 109 | — | — | — | — | — | |
| Net Income | -605 | -605 | -368 | 89 | — | — | — | — | — | |
| EPS (Recurring) | -0.70 | -0.70 | -0.44 | 0.09 | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | -0.70 | -0.70 | -0.44 | 0.09 | — | — | — | — | — | |
| EPS (Diluted) | -0.70 | -0.70 | -0.44 | 0.09 | — | — | — | — | — | |
| EBITDA | 83 | 27 | 950 | 1,004 | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | — | — | — | 116.11 | — | — | — | — | — | |
| Price To Sales Ratio | 0.52 | 0.33 | 0.69 | 1.43 | — | — | — | — | — | |
| Gross Margin | 59.08 | 62.89 | 64.84 | 64.38 | — | — | — | — | — | |
| Operating Margin | 4.99 | -1.39 | 4.09 | 8.94 | — | — | — | — | — | |
| Net Margin | -10.42 | -10.42 | -6.24 | 1.45 | — | — | — | — | — | |
| Shares Outstanding | 880 | 877 | 872 | 874 | — | — | — | — | — | |
| Market Capitalization | 3,023 | 1,894 | 4,055 | 8,757 | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| von Bayern Anna | Chief Corp. Affairs Officer | Oct 19 '26 | Option Exercise | 0.00 | 67,155 | 0 | 1,609,947 | Oct 21 |
| Zafar Ayesha | SVP Group Controller | Oct 19 '26 | Option Exercise | 0.00 | 28,150 | 0 | 201,305 | Oct 21 |
| Blazewicz Kristin | Chief Legal Officer | Oct 19 '26 | Option Exercise | 0.00 | 95,136 | 0 | 1,055,701 | Oct 21 |
| Srinivasan Priya | Chief People & Purpose Officer | Apr 04 '26 | Option Exercise | 0.00 | 4,741 | 0 | 51,133 | Apr 10 |
| von Bretten Gordon | President - Consumer Beauty | Mar 06 '26 | Buy | 2.41 | 83,000 | 200,287 | 986,620 | Mar 09 |
| Mercier Laurent | Chief Financial Officer | Feb 10 '26 | Buy | 2.65 | 5,000 | 13,250 | 500,031 | Feb 18 |
| Makanju Anna Adeola | Director | Dec 18 '25 | Option Exercise | 0.00 | 13,287 | 0 | 13,287 | Jan 05 |
| Singer Robert S | Director | Nov 15 '25 | Option Exercise | 0.00 | 25,000 | 0 | 155,000 | Nov 18 |
| Parize Isabelle | Director | Nov 15 '25 | Option Exercise | 0.00 | 25,000 | 0 | 94,968 | Nov 18 |
| Ballini Beatrice | Director | Nov 15 '25 | Option Exercise | 0.00 | 25,000 | 0 | 52,634 | Nov 18 |
| HARF PETER | Director | Nov 15 '25 | Option Exercise | 0.00 | 45,000 | 0 | 127,657 | Nov 18 |
| Creus Joachim | Director | Nov 15 '25 | Option Exercise | 0.00 | 25,000 | 0 | 31,547 | Nov 18 |
| Ballini Beatrice | Director | Oct 08 '23 | Buy | 9.28 | 20,000 | 185,600 | 20,000 | Nov 18 |
| Ballini Beatrice | Director | Dec 12 '22 | Sale | 7.90 | 7,000 | 55,300 | 0 | Nov 18 |
| Zafar Ayesha | SVP Group Controller | Oct 19 '25 | Option Exercise | 0.00 | 31,994 | 0 | 181,376 | Oct 22 |